Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $10.00 at Mizuho
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its price target decreased by investment analysts at Mizuho from $30.00 to $10.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Mizuho’s target price indicates a potential upside of 458.66% from […]
More Stories
IBM to Pay $17 Million to Settle Allegations of Discrimination
By Jacki Thrapp IBM will pay millions of dollars to resolve allegations that it failed to comply with anti-discrimination requirements...
Trump Says US ‘Loading up the Ships’ Ahead of Iran Talks, Signals Military Option If Diplomacy Fails
By Tom Ozimek President Donald Trump said the United States is preparing military options if negotiations with Iran fail to...
Artemis II Mission Ends With Splashdown Off San Diego
By T.J. Muscaro HOUSTON—Humanity’s first adventure to the moon in more than 50 years is complete. Artemis II, NASA’s 10-day...
Trump Warns Iran Has ‘No Cards’ Except Strait of Hormuz in Peace Talks
By Jack Phillips President Donald Trump on Friday said that the Iranian regime has very few negotiating options ahead of...
State Department Settles Lawsuit Alleging It Censored Conservative Outlets Under Biden
By Jacki Thrapp The Department of Justice (DOJ) settled a lawsuit that accused the Biden administration of censoring speech by...
Supreme Court Upholds Reversal of Death Declaration in Case of Man Found to Be Alive
By The Canadian Press The Supreme Court of Canada has affirmed a judge’s decision to annul the declaration of a...